Correlation Between Pfizer and SOUTHERN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and SOUTHERN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and SOUTHERN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and SOUTHERN PER CORP, you can compare the effects of market volatilities on Pfizer and SOUTHERN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of SOUTHERN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and SOUTHERN.

Diversification Opportunities for Pfizer and SOUTHERN

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and SOUTHERN is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and SOUTHERN PER CORP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SOUTHERN PER P and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with SOUTHERN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SOUTHERN PER P has no effect on the direction of Pfizer i.e., Pfizer and SOUTHERN go up and down completely randomly.

Pair Corralation between Pfizer and SOUTHERN

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the SOUTHERN. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.5 times less risky than SOUTHERN. The stock trades about -0.06 of its potential returns per unit of risk. The SOUTHERN PER CORP is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  9,897  in SOUTHERN PER CORP on September 12, 2024 and sell it today you would lose (123.00) from holding SOUTHERN PER CORP or give up 1.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.48%
ValuesDaily Returns

Pfizer Inc  vs.  SOUTHERN PER CORP

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
SOUTHERN PER P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SOUTHERN PER CORP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SOUTHERN is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and SOUTHERN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and SOUTHERN

The main advantage of trading using opposite Pfizer and SOUTHERN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, SOUTHERN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SOUTHERN will offset losses from the drop in SOUTHERN's long position.
The idea behind Pfizer Inc and SOUTHERN PER CORP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.